Inhalable insulin developer MannKind, based in Westlake Village, announced an agreement with Charlotte, N.C.-based Tanner Pharma Group to distribute its product Afrezza in international markets. Tanner Pharma subsidiary TannerGAP will distribute the product outside the U.S. in regions where it is not yet registered, the company said in a news release July 27. “Al Mann…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
